Caption Management, LLC Xenon Pharmaceuticals Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $2.26 Million - $2.65 Million	-52,900 Reduced 17.56%	248,300 $10.7 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $6.42 Million - $10.4 Million	223,700 Added 288.65%	301,200 $13.9 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $2.65 Million - $3.08 Million	77,500 New	77,500 $2.65 Million
Q1 2023 May 15, 2023	SELL	$33.46 - $40.35 $5.12 Million - $6.18 Million	-153,100 Reduced 75.38%	50,000 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $6.71 Million - $8.01 Million	203,100 New	203,100 $8.01 Million
Q4 2021 Feb 11, 2022	SELL	$15.6 - $35.4 $11 Million - $24.9 Million	-704,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$14.86 - $19.45 $10.5 Million - $13.7 Million	704,200 New	704,200 $10.8 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.